ストックスクリーナーアプリを入手
6.33
12.30%
0.6933
プレマーケット:
6.30
-0.03
-0.47%
前日終値:
$5.6367
開ける：
$6.24
24時間の取引高:
30,494
Relative Volume:
1.88
時価総額：
$8.11M
収益：
$35.75M
当期純損益:
$11.57M
株価収益率:
-1.6628
EPS:
-3.8069
ネットキャッシュフロー:
$-26.25M
1週間 パフォーマンス:
+14.97%
1か月 パフォーマンス:
-2.62%
6か月 パフォーマンス:
-30.31%
1年 パフォーマンス:
-72.99%
1日の値動き範囲:
$6.015
$6.43
1週間の範囲:
$5.57
$6.43
52週間の値動き範囲:
$5.41
$31.50
Redhill Biopharma Ltd Adr Stock (RDHL) Company Profile
RDHL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RDHL
Redhill Biopharma Ltd Adr
|
6.33 | 8.11M | 35.75M | 11.57M | -26.25M | -3.8069 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Redhill Biopharma Ltd Adr Stock (RDHL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-08-31 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-05-18 | 開始されました | H.C. Wainwright | Buy |
| 2020-09-11 | 開始されました | BTIG Research | Buy |
| 2019-07-12 | アップグレード | WBB Securities | Buy → Strong Buy |
| 2019-03-12 | アップグレード | WBB Securities | Speculative Buy → Buy |
| 2018-01-26 | 開始されました | Nomura | Buy |
| 2017-10-06 | 開始されました | Seaport Global Securities | Buy |
| 2017-10-04 | 繰り返されました | H.C. Wainwright | Buy |
| 2017-02-24 | 繰り返されました | FBR & Co. | Outperform |
| 2016-07-27 | 繰り返されました | FBR Capital | Outperform |
| 2015-09-29 | 開始されました | Nomura | Buy |
| 2015-07-29 | 繰り返されました | ROTH Capital | Buy |
| 2015-06-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2015-06-15 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Redhill Biopharma Ltd Adr (RDHL) 最新ニュース
RedHill stock rises on expanded Medicare coverage - Investing.com
GAMMA Investing LLC Buys 595 Shares of ArcelorMittal S.A. (NYSE:MT) - Defense World
RedHill wins $8 million judgment in New York court - Investing.com India
RedHill Biopharma: FDA Accepts TALICIA’s NDA - Investing.com
COVID-19 Competitive Landscape 2024 (Updated) - openPR
BARDA funds RedHill's opaganib for Ebola treatment - Investing.com
Medi-Cal extends Talicia access for 15 million Californians - Investing.com
RedHill's Talicia® Listed as First-Line Choice for H. pylori in New American College of Gastroenterology Guidelines - StockTitan
Can Redhill Biopharma Ltd. ADR Bounce Back? 52-Week Performance and Analyst Predictions - The InvestChronicle
RDHL stock’s current quarter earnings estimates: What analysts predict? - US Post News
Talicia® Launched in the United Arab Emirates - StockTitan
Taking on analysts’ expectations and winning: Redhill Biopharma Ltd. ADR (RDHL) - SETE News
Redhill Biopharma stock hits 52-week high of $8.03 amid volatility - Investing.com
Opaganib shows promise in obesity, diabetes treatment - Investing.com India
Balance Sheet Breakdown: Redhill Biopharma Ltd. ADR (RDHL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Redhill Biopharma Ltd. ADR’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
RedHill Biopharma Announces Positive Obesity and Diabetes Results with Opaganib - Investing.com
Teva Pharmaceutical Industries Limited (TEVA) Stock Price, News, Quote & History - Yahoo Finance
RedHill Biopharma Announces Plan to Implement ADS Ratio Change - PR Newswire
Its Stock Has Paid Off Big Time For Teck Resources Ltd - SETE News
Are Smart Investors Making the Right Decision? Redhill Biopharma Ltd. ADR (RDHL) - SETE News
Check Out Aveanna Healthcare Holdings Inc (AVAH)’s Trade Data Rather Than the Analysts’ Views - SETE News
RDHL’s Stock Tango: The Dance of Gains and Losses in 2023 - The InvestChronicle
Can you now get a good deal on Redhill Biopharma Ltd. ADR’s shares? - US Post News
Is ThredUp Inc (TDUP) positioned for future growth? - SETE News
A look into Redhill Biopharma Ltd. ADR (RDHL)’s deeper side - SETE News
Immuneering Corp (IMRX) expanding its growth trajectory ahead - SETE News
Cipher Mining Inc (CIFR) is looking forward to a strong quarter - SETE News
Nothing is Better Than Hut 8 Corp (HUT) stock at the moment - SETE News
Analytical Overview: Redhill Biopharma Ltd. ADR (RDHL)’s Ratios Tell a Financial Story - The Dwinnex
Redhill Biopharma Ltd. ADR [RDHL] Revenue clocked in at $35.52 million, down -68.49% YTD: What’s Next? - The DBT News
Redhill Biopharma Ltd. ADR Inc. (RDHL) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Should investors be concerned about RDHL’s high price-to-sales ratio? - US Post News
Exact Sciences Corp. (EXAS) Stock: A Year of Decreases and Increases - The InvestChronicle
New Outlook On Alibaba Group Holding Ltd ADR - Stocks Register
Baker Hughes Co (NASDAQ: BKR) Up 1.26%: This Is What Analysts Are Now Forecasting - Stocks Register
RedHill Biopharma finalizes agreement to enhance cash position - Investing.com
RedHill secures new US patent for H. pylori treatment Talicia - Investing.com
RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 - PR Newswire
Balancing Acidity: Exploring the Proton Pump Inhibitors Market - openPR
symbol__ Stock Quote Price and Forecast - CNN
RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034 - PR Newswire
LLY Stock Quote Price and Forecast - CNN
RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S. - PR Newswire
Phil and RedHill Biopharma Partner to Increase Access to Talicia® - Business Wire
Peptic Ulcer Drugs Market Drivers Analysis | CAGR of 3.5% - Market.us
Benign Growth For RedHill Biopharma Ltd. (NASDAQ:RDHL) Underpins Stock's 41% Plummet - Yahoo Finance
RedHill’s Aemcolo® Granted FDA QIDP 5-Year Exclusivity Extension - BioSpace
RedHill presents New Talicia® and Movantik® data analyses at ACG 2022 - EurekAlert
Cathie Wood Predictions 2022 - New Trader U
RedHill presents new Talicia® data analyses at DDW 2022 - EurekAlert
Redhill Biopharma Ltd Adr (RDHL) 財務データ
収益
当期純利益
現金流量
EPS
2.14%
大文字化:
|
ボリューム (24 時間):